********************************************************************************************** ** ** ** SNPs&GO ** ** Predicting disease associated variation using GO terms ** ** ** ********************************************************************************************** Sequence File: fileseq.seq Mutation Prediction RI Probability Method L23I Neutral 4 0.287 PhD-SNP: F[L]=100% F[I]=0% Nali=36 L23I Disease 1 0.568 PANTHER: F[L]=77% F[I]=4% L23I Neutral 7 0.149 SNPs&GO E129K Disease 3 0.651 PhD-SNP: F[E]=71% F[K]=0% Nali=34 E129K Neutral 2 0.414 PANTHER: F[E]=59% F[K]=3% E129K Neutral 2 0.405 SNPs&GO S179T Neutral 7 0.131 PhD-SNP: F[S]=86% F[T]=11% Nali=35 S179T Disease 3 0.636 PANTHER: F[S]=72% F[T]=3% S179T Neutral 8 0.112 SNPs&GO I404M Neutral 7 0.126 PhD-SNP: F[I]=34% F[M]=18% Nali=60 I404M Disease 4 0.703 PANTHER: F[I]=65% F[M]=1% I404M Neutral 6 0.222 SNPs&GO R414H Disease 2 0.606 PhD-SNP: F[R]=67% F[H]=5% Nali=62 R414H Disease 3 0.628 PANTHER: F[R]=61% F[H]=1% R414H Neutral 1 0.465 SNPs&GO T562M Neutral 4 0.280 PhD-SNP: F[T]=34% F[M]=0% Nali=73 T562M Disease 3 0.637 PANTHER: F[T]=53% F[M]=1% T562M Neutral 5 0.261 SNPs&GO N818D Neutral 3 0.326 PhD-SNP: F[N]=47% F[D]=0% Nali=35 N818D Neutral 3 0.332 PANTHER: F[N]=54% F[D]=4% N818D Neutral 8 0.122 SNPs&GO R945K Neutral 0 0.491 PhD-SNP: F[R]=94% F[K]=0% Nali=31 R945K Disease 2 0.597 PANTHER: F[R]=80% F[K]=4% R945K Neutral 3 0.350 SNPs&GO S948P Neutral 8 0.102 PhD-SNP: F[S]=25% F[P]=34% Nali=31 S948P Neutral 8 0.115 PANTHER: F[S]=34% F[P]=13% S948P Neutral 10 0.011 SNPs&GO S1400L Neutral 7 0.168 PhD-SNP: F[S]=88% F[L]=0% Nali=31 S1400L Neutral 0 0.499 PANTHER: F[S]=54% F[L]=2% S1400L Neutral 8 0.079 SNPs&GO A1755V Neutral 8 0.081 PhD-SNP: F[A]=41% F[V]=0% Nali=16 A1755V Unclassified NA NA PANTHER: F[A]=NA F[V]=NA A1755V Neutral 10 0.023 SNPs&GO V1804L Neutral 9 0.063 PhD-SNP: F[V]=29% F[L]=0% Nali=13 V1804L Neutral 8 0.094 PANTHER: F[V]=10% F[L]=5% V1804L Neutral 10 0.012 SNPs&GO S2029F Neutral 3 0.347 PhD-SNP: F[S]=95% F[F]=0% Nali=21 S2029F Disease 3 0.652 PANTHER: F[S]=54% F[F]=1% S2029F Neutral 7 0.140 SNPs&GO W2101G Disease 3 0.628 PhD-SNP: F[W]=92% F[G]=0% Nali=23 W2101G Disease 3 0.643 PANTHER: F[W]=69% F[G]=1% W2101G Neutral 0 0.479 SNPs&GO A2121V Neutral 4 0.275 PhD-SNP: F[A]=79% F[V]=0% Nali=23 A2121V Neutral 2 0.394 PANTHER: F[A]=57% F[V]=3% A2121V Neutral 8 0.092 SNPs&GO S2627Y Neutral 7 0.144 PhD-SNP: F[S]=47% F[Y]=0% Nali=16 S2627Y Unclassified NA NA PANTHER: F[S]=NA F[Y]=NA S2627Y Neutral 10 0.024 SNPs&GO Mutation: WT+POS+NEW WT: Residue in wild-type protein POS: Residue position NEW: New residue after mutation Prediction: Neutral: Neutral variation Disease: Disease associated variation RI: Reliability Index Probability: Disease probability (if >0.5 mutation is predicted Disease) Method: SVM type and data PANTHER: Output of the PANTHER algorithm PhD-SNP: SVM input is the sequence and profile at the mutated position SNPs&GO: SVM input is all the input in PhD-SNP, PANTHER and GO term features F[X]: Frequency of residue X in the sequence profile Nali: Number of aligned sequences in the mutated site ********************************************************************************************** ** ** ** Calabrese R, Capriotti E, Fariselli P, Martelli PL, Casadio R. (2009). Functional ** ** annotations improve the predictive score of human disease-related mutations in ** ** proteins. Human Mutation. 30:1237-1244. ** ** ** ** Capriotti E, Altman RB. (2011). Improving the prediction of disease-related vari- ** ** ants using protein three-dimensional structure. BMC Bioinformatics. 12 (Sup.4) S3. ** ** ** **********************************************************************************************